(Q22241462)

PubMed

PubMed publication ID

15967835

7 February 2023

Liron Pantanowitz

author given names

Liron

author last names

Pantanowitz

series ordinal

2

1 reference

PubMed

PubMed publication ID

15967835

7 February 2023

Bruce J Dezube

author given names

Bruce J

author last names

Dezube

series ordinal

3

1 reference

PubMed

PubMed publication ID

15967835

Association of Cancer With AIDS-Related Immunosuppression in Adults

7 February 2023

language of work or name

English

0 references

publication date

1 June 2005

0 references

published in

Oncologist

0 references

volume

10

0 references

issue

6

0 references

page(s)

412-426

0 references

cites work

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Hyperviscosity syndrome secondary to a myeloma-associated IgG(1)kappa paraprotein strongly reactive against the HIV-1 p24 gag antigen

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Neoplasia of plasma cells with atypical presentation and infection by the human immunodeficiency virus. A presentation of two cases

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Multiple myeloma and human immunodeficiency virus-1 (HIV-1) infection

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Kaposi's sarcoma of internal organs. A multiparameter study of 86 cases

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988-1998.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

The evidence-based treatment of AIDS-related non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Kaposi's sarcoma-associated herpesvirus infection of blood endothelial cells induces lymphatic differentiation

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

AIDS across Europe, 1994-98: the EuroSIDA study

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

KAPOSI'S SARCOMA IN HOMOSEXUAL MEN—A REPORT OF EIGHT CASES

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Spectrum of AIDS-associated malignant disorders

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Multidrug resistance (MDR-1) expression in AIDS-related lymphomas

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Biology and management of AIDS-associated non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Clinical presentations and standard therapy of AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Hodgkin's disease in HIV.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Epidemiology of AIDS-related malignancies an international perspective

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

AIDS and cancer in the era of highly active antiretroviral therapy (HAART).

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Clinical aspects and management of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Clinical aspects and management of AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Highly active antiretroviral therapy in HIV-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Monoclonal antibody D2-40, a new marker of lymphatic endothelium, reacts with Kaposi's sarcoma and a subset of angiosarcomas

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Lymphatic reprogramming of blood vascular endothelium by Kaposi sarcoma–associated herpesvirus

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

High-dose chemotherapy and autologous CD34-positive blood stem cell transplantation for multiple myeloma in an HIV carrier

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Should HIV-positive patients with lymphoma be offered stem cell transplants?

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Paraproteinemia, plasmacytoma, myeloma and HIV infection

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Histological characterization of regression in acquired immunodeficiency syndrome-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Preliminary communication: matrix metalloproteinases in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Plasmablastic lymphoma in HIV+ patients: an expanding spectrum

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Brief report: myeloma-associated paraprotein directed against the HIV-1 p24 antigen in an HIV-1-seropositive patient

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

A prospective, randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Français du Myélome

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

HIV-1-Tat protein activates phosphatidylinositol 3-kinase/ AKT-dependent survival pathways in Kaposi's sarcoma cells

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Interleukin-2, ganciclovir, and high-dose zidovudine for the treatment of AIDS-associated primary central nervous system lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994-1998.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Relationship of Kaposi Sarcoma (KS)–Associated Herpesvirus Viremia and KS Disease in Zimbabwe

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Plasma cell myeloma in patients who are HIV-positive

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Plasma cell malignancy in the acquired immune deficiency syndrome. Association with Epstein-Barr virus

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Cancer incidence in New York State acquired immunodeficiency syndrome patients.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

BEACOPP therapeutic regimen for patients with Hodgkin’s disease and HIV infection

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Use of antiherpes drugs and the risk of Kaposi's sarcoma: data from the Multicenter AIDS Cohort Study

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

In situ study of chemokine and chemokine-receptor expression in Kaposi sarcoma.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma: an immunohistochemical study of 16 cases

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Epidemiologic trends in HIV-associated lymphomas

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

B-cell activation and lymphoma in patients with HIV.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Plasma cell dyscrasia, Hodgkin lymphoma, HIV, and Kaposi sarcoma-associated herpesvirus

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Update in Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Leptomeningeal disease in AIDS-related non-Hodgkin's lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Response to highly active antiretroviral therapy strongly predicts outcome in patients with AIDS-related lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

The natural history and molecular heterogeneity of HIV-associated primary malignant lymphomatous effusions

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Immune deficiency and risk for malignancy among persons with AIDS

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

KSHV-positive solid lymphomas represent an extra-cavitary variant of primary effusion lymphoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

IgA kappa multiple myeloma and lymphadenopathy syndrome associated with AIDS virus infection

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

AIDS-related malignancies

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Presentation of AIDS-related pulmonary Kaposi's sarcoma diagnosed by bronchoscopy

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Kaposi's sarcoma of the larynx

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Selective expression of stromal-derived factor-1 in the capillary vascular endothelium plays a role in Kaposi sarcoma pathogenesis

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Rituximab plus infusional cyclophosphamide, doxorubicin, and etoposide in HIV-associated non-Hodgkin lymphoma: pooled results from 3 phase 2 trials.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Gene expression profile of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Kaposi's sarcoma in the acquired immune deficiency syndrome: a proposal for uniform evaluation, response, and staging criteria. AIDS Clinical Trials Group Oncology Committee

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Prognostic factors in the treatment of human immunodeficiency virus-associated non-Hodgkin's lymphoma: analysis of AIDS Clinical Trials Group protocol 142--low-dose versus standard-dose m-BACOD plus granulocyte-macrophage colony-stimulating factor.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Activity of thalidomide in AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Unusual presentations of malignancy. Case 2. Breast plasmacytoma in a patient with human immunodeficiency virus

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494).

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Liposome-encapsulated doxorubicin in combination with standard agents (cyclophosphamide, vincristine, prednisone) in patients with newly diagnosed AIDS-related non-Hodgkin's lymphoma: results of therapy and correlates of response

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Antiretroviral treatment regimens and immune parameters in the prevention of systemic AIDS-related non-Hodgkin's lymphoma.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Unusual sites of Hodgkin's lymphoma: CASE 1. HIV-associated Hodgkin's lymphoma of the stomach

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Imatinib-induced regression of AIDS-related Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Angiogenesis Inhibitor IM862 Is Ineffective Against AIDS-Kaposi's Sarcoma in a Phase III Trial, but Demonstrates Sustained, Potent Effect of Highly Active Antiretroviral Therapy: From the AIDS Malignancy Consortium and IM862 Study Team

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Treating Kaposi's lesions in the HIV-infected patient

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981-1986)

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021

Disseminated Kaposi's sarcoma in homosexual men.

1 reference

https://api.crossref.org/works/10.1634%2FTHEONCOLOGIST.10-6-412

7 January 2021